Is This Inhaler Effective for Respiratory Viruses?
Budesonide, an inhaled glucocorticoid often used by people with asthma and COPD, was effective in improving COVID-19 outcomes when administered within the first seven days of the onset of symptoms.
Originally published on 3/17/21
STORY AT-A-GLANCE
Researchers conducted a randomized trial to determine if budesonide, when used early during COVID-19 infection, would improve outcomes
Inhaled budesonide lowered the relative risk of needing urgent care or hospitalization by 90% over 28 days, while also resolving fever and other symptoms faster and leading …
Keep reading with a 7-day free trial
Subscribe to Dr. Mercola's Censored Library (Private Membership) to keep reading this post and get 7 days of free access to the full post archives.